Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",42097,231,1.03 [0.91-1.16],0.6365901996286565
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",43553,329,0.99 [0.89-1.09],0.8056273760381569
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",43118,2283,1.04 [1.00-1.08],0.066892553215885
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Candidiasis,43591,699,1.01 [0.94-1.08],0.8278495286176167
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,42260,5824,1.02 [1.00-1.05],0.0533396769564626
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),42466,5302,1.01 [0.98-1.03],0.5584104091470848
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,43174,2022,1.02 [0.98-1.07],0.2618285089024847
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,43438,144,0.95 [0.82-1.11],0.5186762200385377
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,40178,1581,1.00 [0.95-1.05],0.9598472755897776
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,38771,1762,1.01 [0.96-1.05],0.7443684030900923
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,38649,414,1.01 [0.92-1.11],0.8367021798923668
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,30576,3261,1.01 [0.98-1.04],0.5338861082974087
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,38401,641,1.07 [0.99-1.15],0.0796278905450624
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,43527,2375,1.01 [0.98-1.05],0.5049518218351996
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Mycoses,43718,826,1.00 [0.94-1.07],0.9554859052418953
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,42361,1526,1.03 [0.99-1.09],0.1564671608361227
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,43609,1743,1.00 [0.96-1.04],0.9768688310212014
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,41483,331,0.98 [0.89-1.09],0.7630539328163437
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Other infectious diseases,43812,77,1.12 [0.90-1.39],0.3041168611313614
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Other septicaemia,43392,1526,0.99 [0.95-1.04],0.7717289908615032
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,43422,128,1.03 [0.88-1.22],0.6865704094128349
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Other viral diseases,43669,263,1.14 [1.01-1.28],0.0283129030469968
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",43639,233,1.15 [1.01-1.30],0.0309910381827755
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,41520,685,1.07 [1.00-1.15],0.0557186221589163
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,41291,456,1.02 [0.94-1.11],0.6289544965105434
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,41318,166,1.07 [0.93-1.24],0.3280580564923451
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Viral hepatitis,43772,93,0.96 [0.80-1.16],0.6865163068476867
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,43696,261,1.01 [0.90-1.13],0.860271277498319
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Viral warts,43522,87,1.10 [0.90-1.34],0.3692230275916678
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],43551,116,0.98 [0.82-1.16],0.8142256190905183
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign lipomatous neoplasm,43313,497,1.03 [0.95-1.12],0.5112140792602266
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,43663,102,1.05 [0.87-1.27],0.5893342854655725
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,43622,106,1.17 [0.97-1.40],0.1033677921534024
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,20061,102,1.01 [0.84-1.21],0.9295684349533442
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",43243,2427,1.00 [0.96-1.03],0.8333413613647968
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm of meninges,43787,98,1.02 [0.85-1.23],0.8253871456091026
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,43702,115,0.99 [0.83-1.18],0.9107864893921228
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,43768,180,1.04 [0.90-1.19],0.6008828295591648
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm of ovary,23644,149,1.02 [0.88-1.19],0.8073951742992069
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm: Ascending colon,43769,617,0.97 [0.90-1.04],0.3476626591302806
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm: Caecum,43778,504,0.99 [0.92-1.08],0.8946722028045943
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",43619,123,0.95 [0.81-1.12],0.5704205210448745
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm: Descending colon,43771,371,0.98 [0.89-1.07],0.6169986338066423
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm: Rectum,43694,590,0.96 [0.89-1.03],0.2445683978760572
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,43612,1073,1.01 [0.95-1.06],0.850667191785122
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm: Transverse colon,43760,715,1.00 [0.93-1.07],0.992879773022883
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Carcinoma in situ of breast,19191,120,0.82 [0.70-0.97],0.0188924750883643
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",19262,139,0.94 [0.81-1.10],0.4595343678844871
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",34914,93,0.93 [0.77-1.12],0.4467473561843078
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",34939,118,1.01 [0.85-1.20],0.8959610800457902
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",43723,203,0.91 [0.80-1.03],0.1440996478772042
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Haemangioma, any site",43724,198,0.91 [0.80-1.04],0.1760590368318176
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Leiomyoma of uterus,22843,501,0.96 [0.88-1.04],0.2775511927752857
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Lung cancer and mesothelioma,30410,581,0.99 [0.92-1.07],0.8725325488651192
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Lymphoid leukaemia,34911,90,0.91 [0.75-1.10],0.3133483369117548
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",35133,312,1.09 [0.98-1.22],0.0990079687570626
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",35152,331,0.99 [0.90-1.10],0.9142540330331445
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",19390,164,0.90 [0.78-1.03],0.1289117888490582
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",34959,138,0.94 [0.80-1.10],0.4241047724154475
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",34999,178,1.08 [0.93-1.24],0.3082097896111103
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",34997,176,0.97 [0.84-1.12],0.6725082822104438
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",19352,126,1.02 [0.86-1.20],0.8484410475766744
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",34980,159,1.02 [0.88-1.18],0.770865012102378
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",16741,1146,0.96 [0.91-1.02],0.157339224504191
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",35013,192,0.94 [0.83-1.08],0.3804581758169872
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",34950,129,1.08 [0.92-1.28],0.3360168936354966
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,34994,173,0.95 [0.83-1.10],0.4981415212227446
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Melanocytic naevi,43480,347,1.05 [0.95-1.17],0.3007239496884285
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Melanocytic naevi of trunk,43747,152,1.09 [0.94-1.27],0.2639820413139629
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Melanoma in situ,34878,138,1.13 [0.96-1.33],0.12727784607731
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",34981,160,1.03 [0.89-1.19],0.6948167451137803
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",35096,275,1.02 [0.91-1.14],0.7735416544850314
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",35222,401,0.93 [0.85-1.02],0.1185993949319586
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",34991,170,1.03 [0.89-1.19],0.6712808990670402
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Other benign neoplasms of skin,43509,272,0.98 [0.88-1.10],0.7777443289904421
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",36628,1807,0.97 [0.93-1.01],0.1541504965545894
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",36723,1902,0.98 [0.94-1.02],0.2652275105674934
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,43312,575,0.97 [0.90-1.05],0.4193809180123982
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,40674,146,1.13 [0.97-1.33],0.1161859098116789
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,42861,124,1.09 [0.92-1.28],0.3365639795357159
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,42497,4818,1.03 [1.01-1.06],0.0155373973213056
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,41381,79,1.40 [1.12-1.75],0.00318777900172
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,43114,89,1.14 [0.94-1.40],0.1893905061260978
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,43020,2492,1.03 [0.99-1.07],0.1055010388426338
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,43018,2490,1.03 [0.99-1.07],0.1166352309144525
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,40670,142,0.96 [0.82-1.12],0.5877176046541485
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,43265,1963,1.11 [1.06-1.16],2.299089263498719e-06
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,43217,192,0.99 [0.87-1.13],0.8715220234958845
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,42841,104,0.96 [0.80-1.15],0.6647581377179843
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,42842,105,1.07 [0.89-1.28],0.4724749772397845
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,43492,467,0.86 [0.79-0.94],0.0004806906680687
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,43636,92,1.14 [0.94-1.39],0.1869123273516309
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",43412,387,0.78 [0.71-0.85],3.9760489694456857e-08
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,41476,174,1.07 [0.93-1.23],0.3769554424795329
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,34056,506,0.97 [0.89-1.05],0.3936310947704631
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,40853,191,1.06 [0.93-1.22],0.3887063235167098
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,40879,217,1.04 [0.91-1.18],0.5724661212510764
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,33645,95,1.16 [0.96-1.41],0.1305686926274695
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,40726,106,0.90 [0.75-1.07],0.2220534031228242
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,39782,390,0.93 [0.85-1.02],0.115252341238339
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",43042,891,0.95 [0.89-1.01],0.1046751208712095
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,42605,454,0.92 [0.84-1.00],0.0581748450491913
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,42328,177,1.07 [0.93-1.23],0.3768526471506196
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Depression,43233,2613,1.05 [1.01-1.09],0.011411611083687
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,38254,2542,1.05 [1.01-1.09],0.0132420904928475
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",33651,101,0.98 [0.81-1.18],0.8302719404189001
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",40464,136,1.03 [0.88-1.21],0.7155635003488356
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,34011,461,1.08 [0.99-1.18],0.0720309024161477
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,33652,102,1.14 [0.94-1.37],0.1862443908777231
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,39452,5902,1.05 [1.03-1.08],1.949590322060019e-05
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,33879,329,0.97 [0.87-1.07],0.5147869744089135
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,34474,924,1.05 [0.98-1.11],0.1447445413377756
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,43680,530,1.10 [1.01-1.19],0.0269205395159562
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,43363,213,1.09 [0.95-1.23],0.2106304646189883
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,33760,210,1.03 [0.91-1.17],0.6466001341786063
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",33653,103,0.95 [0.79-1.14],0.5915677267688185
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,42898,2570,1.05 [1.01-1.09],0.0138833010245061
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,33975,425,1.00 [0.92-1.10],0.9752185482146428
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,34005,455,0.93 [0.86-1.02],0.1079251948136461
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",34601,1051,1.07 [1.01-1.13],0.0252611203118385
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,33732,182,0.95 [0.83-1.09],0.4491028849779932
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,43353,203,1.08 [0.95-1.23],0.2527011117799848
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,34565,1015,1.03 [0.97-1.09],0.3794541402496812
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,34351,801,1.02 [0.95-1.08],0.6464836093937497
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,39503,111,1.09 [0.91-1.31],0.3356742135883117
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,41892,8342,1.04 [1.02-1.06],0.0006965331535304
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,40403,75,0.98 [0.79-1.21],0.8473164335254922
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,40426,98,1.02 [0.84-1.23],0.8555046704386633
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,43507,3259,1.00 [0.97-1.03],0.8703622551997414
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",43507,3253,1.00 [0.97-1.03],0.885336907088109
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,40415,87,1.15 [0.94-1.41],0.1867508197992584
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,43232,2044,1.03 [0.99-1.08],0.1039396620027382
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",36166,2616,1.01 [0.97-1.04],0.7727498890488332
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,43792,353,0.91 [0.82-1.00],0.0440533428434078
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,42273,122,0.91 [0.78-1.08],0.278896008751021
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,41364,176,0.99 [0.86-1.14],0.9136357005006608
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,41429,241,1.13 [1.00-1.28],0.0480405924182674
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",33826,276,1.11 [0.99-1.24],0.0852644329759845
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,39887,263,1.07 [0.95-1.20],0.2594921186323716
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,3611,140,0.95 [0.82-1.11],0.55421192828733
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,3838,411,0.99 [0.90-1.08],0.7584085870808509
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,39729,105,1.12 [0.93-1.35],0.2241394951519901
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,3549,79,0.86 [0.70-1.05],0.1271640272500586
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,42761,3137,1.06 [1.02-1.09],0.0009618218535929
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,42714,563,0.90 [0.83-0.97],0.0047836050380713
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,40002,610,0.98 [0.91-1.06],0.6235283661338504
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,34793,1243,1.01 [0.96-1.07],0.6587447119459979
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",43616,413,0.90 [0.82-0.98],0.017245119352505
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),41917,276,0.93 [0.83-1.04],0.189423946283695
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Angina pectoris,40089,1979,1.01 [0.97-1.05],0.6973144010232195
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Aortic aneurysm,42048,407,0.94 [0.86-1.03],0.2018153317554555
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,41736,95,1.16 [0.96-1.41],0.1239053768608107
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",41966,325,1.05 [0.95-1.16],0.345500674426034
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,27198,3180,0.97 [0.94-1.00],0.0577628784066596
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,AV-block,37002,714,0.99 [0.92-1.06],0.6866188957685835
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",43713,695,0.94 [0.87-1.00],0.0687878842641492
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Cardiac arrest,24333,315,1.03 [0.93-1.14],0.5902762463549983
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Cardiomyopathy,36575,287,0.89 [0.80-0.99],0.033939693060436
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",36449,161,0.97 [0.84-1.12],0.6705713279135541
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,43808,76,0.95 [0.77-1.17],0.6550940416758555
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Conduction disorders,38045,1757,0.99 [0.95-1.04],0.7995425272081718
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,41555,3476,1.02 [0.99-1.05],0.1849439242001757
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Death due to cardiac causes,38364,12888,1.01 [1.00-1.03],0.087736562458826
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,DVT of lower extremities,41484,447,0.91 [0.84-1.00],0.0402439200499829
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Endocarditis,36405,117,0.97 [0.82-1.15],0.7402358512891944
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Heart failure, strict",43464,1829,1.03 [0.99-1.08],0.1649962224133245
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Hypertension,39897,11010,1.03 [1.01-1.04],0.0053145120783632
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Hypertension, essential",39910,11023,1.03 [1.01-1.04],0.0055746832575247
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Hypertension, portal",43514,136,0.81 [0.70-0.95],0.0073853250643718
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",29207,320,1.00 [0.90-1.11],0.9744296109358742
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,29055,168,1.00 [0.87-1.15],0.9898476706927544
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Hypotension,43573,1914,1.01 [0.96-1.05],0.8087284771064698
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,42281,181,0.96 [0.84-1.10],0.5812650125439345
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",41849,3739,1.02 [0.99-1.05],0.2393981449273055
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",43196,938,1.05 [0.99-1.12],0.0963306332547464
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Left bundle-branch block,36896,608,1.00 [0.93-1.08],0.9437628470560924
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Major coronary heart disease event,43037,1419,1.03 [0.98-1.08],0.2425155089707373
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",39306,1196,1.04 [0.99-1.10],0.1544582827809009
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",43650,270,1.08 [0.96-1.21],0.2042704701523809
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",43761,521,1.03 [0.95-1.12],0.4101243800985599
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Oesophageal varices,41126,89,0.80 [0.66-0.96],0.0165307460987906
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other aneurysm,41770,129,1.02 [0.87-1.20],0.7990867893846768
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other arrhythmias,37005,717,1.00 [0.94-1.07],0.9362708895230958
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,41809,168,1.12 [0.97-1.29],0.1220240520835634
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,42035,394,0.99 [0.90-1.08],0.8110861141395374
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other diseases of pericardium,36592,304,1.00 [0.90-1.11],0.98355819784057
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other disorders of veins,41189,152,0.99 [0.85-1.15],0.8632483059668667
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,41121,84,1.10 [0.90-1.35],0.3621317483443022
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,41449,104,0.98 [0.82-1.18],0.8566146498060938
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,41259,222,1.00 [0.88-1.13],0.976008515987338
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,37990,1702,0.99 [0.94-1.03],0.5771637041373182
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,41751,92,0.88 [0.73-1.06],0.1740232429191817
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,42555,914,1.01 [0.95-1.07],0.8439523207196749
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,42772,600,0.99 [0.92-1.07],0.8616642297201043
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",42349,1004,1.01 [0.95-1.07],0.8435898336680021
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,24577,559,0.97 [0.89-1.05],0.3949531699583469
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Peripheral artery disease,42260,674,1.02 [0.95-1.10],0.5547890450771447
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),41613,576,0.95 [0.88-1.02],0.1824755183757591
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Pulmonary embolism,42958,786,1.00 [0.93-1.07],0.9531721293520936
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,43691,1079,0.99 [0.94-1.05],0.731840135751939
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Right bundle-branch block,36870,582,0.98 [0.91-1.06],0.6782573733347947
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Secondary right heart disease,42764,592,0.99 [0.92-1.07],0.8775436262924273
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,41658,313,0.99 [0.89-1.10],0.8106375862995527
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",43175,1075,1.04 [0.99-1.10],0.1397952147671987
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Stroke, including SAH",43141,1140,1.04 [0.98-1.10],0.2000911836729841
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,42233,99,0.97 [0.81-1.17],0.7747010707010216
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,41770,130,0.94 [0.80-1.10],0.4335540521733372
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Transient ischemic attack,42638,380,1.11 [1.01-1.22],0.0356525635641841
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Unstable angina pectoris,42050,432,1.04 [0.95-1.13],0.4503268286530678
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Varicose veins,41735,698,1.00 [0.93-1.07],0.9129353138026288
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,41666,141,0.91 [0.78-1.05],0.1986744101323975
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Venous thromboembolism,43418,1238,0.98 [0.93-1.03],0.3987041813432491
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",43608,611,1.00 [0.93-1.08],0.9473631027990176
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",38404,2413,1.04 [1.00-1.08],0.0476351893655537
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,Any mental disorder,42717,6726,1.02 [1.00-1.04],0.1248416210306551
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",43530,715,0.99 [0.93-1.07],0.8800512170916451
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",38651,2660,1.04 [1.00-1.08],0.0271213663988806
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",36130,139,1.04 [0.89-1.22],0.5864457207740525
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,Smoking dependency,42900,2322,1.01 [0.97-1.05],0.643208668415445
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",38752,2761,1.01 [0.98-1.05],0.5659058140533951
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,Vascular dementia,43007,210,0.92 [0.82-1.05],0.2237360982778115
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Alzheimer disease,43810,566,0.94 [0.87-1.01],0.0905014168433842
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",29698,100,0.94 [0.78-1.13],0.4996652829047849
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Bell's palsy,40802,137,1.00 [0.85-1.17],0.9948427267553244
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,41511,846,1.04 [0.97-1.11],0.2379119184089775
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Cerebral cysts,43127,374,0.99 [0.90-1.09],0.784166428831041
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,43675,525,0.95 [0.88-1.03],0.2421302410603097
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,42985,93,1.05 [0.86-1.27],0.6541223608571546
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,43784,109,0.95 [0.80-1.13],0.546367307680183
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",42871,118,0.93 [0.79-1.10],0.4201592364124928
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Epilepsy,41209,475,0.94 [0.87-1.03],0.1821765889770542
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,43002,2268,1.03 [0.99-1.07],0.1952915441297425
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,43733,695,0.98 [0.91-1.05],0.5526035833383034
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Falls/tendency to fall,42820,4266,0.95 [0.92-0.98],0.0003308088928502
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Generalized epilepsy,43178,90,1.14 [0.94-1.40],0.1844687204410521
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Hemiplegia,43561,411,0.99 [0.91-1.09],0.8694223614690284
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Hydrocephalus,42856,103,1.02 [0.85-1.23],0.8071533307804272
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,43779,116,1.15 [0.96-1.37],0.1193654044185883
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Lesion of plantar nerve,40794,129,0.85 [0.73-0.99],0.0410875062731902
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,40795,130,1.01 [0.86-1.18],0.9392253091628354
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Memory loss,42763,200,0.96 [0.85-1.10],0.5728666636506317
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Migraine,41333,599,1.09 [1.01-1.18],0.0273542455598904
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",43692,543,1.09 [1.00-1.18],0.0471155674260653
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Motor neuron disease,29890,255,1.04 [0.93-1.17],0.4705164331105901
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,43520,186,0.99 [0.86-1.13],0.8597869312898084
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",42688,2023,1.03 [0.99-1.07],0.1812984304721165
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Neurological diseases,41305,6169,1.01 [0.98-1.03],0.656464201909734
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,43201,309,0.99 [0.89-1.10],0.8069565475435677
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",41345,680,1.04 [0.96-1.11],0.3340400725720626
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",43685,493,1.01 [0.93-1.10],0.7978616488994739
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,35061,1088,0.97 [0.91-1.02],0.2330140351991101
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Other diseases of spinal cord,42872,119,0.91 [0.77-1.07],0.2626903815492923
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Other disorders of nervous system,42989,236,0.93 [0.83-1.05],0.2620462010704544
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,43286,248,1.02 [0.90-1.14],0.7840388216289792
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Other facial nerve disorders,40827,162,0.99 [0.85-1.14],0.8460376867306395
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Other headache syndromes,40836,102,1.04 [0.87-1.26],0.6442506961814611
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Other neurological diseases,43613,860,0.99 [0.93-1.06],0.8358320966961149
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Other sleep disorders,41658,924,1.01 [0.95-1.08],0.6389819108376905
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Parkinson's disease,43766,407,0.94 [0.86-1.03],0.1922998700341722
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,42848,95,1.06 [0.87-1.29],0.5415232380739526
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Restless leg syndrome,43808,109,1.03 [0.86-1.23],0.754920590940994
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Sleep apnoea,43411,802,1.02 [0.96-1.09],0.5211887856862171
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Small fibre neuropathy,43275,83,1.07 [0.87-1.31],0.545312642927752
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,43784,299,1.01 [0.90-1.12],0.902481731970604
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Trigeminal neuralgia,40751,86,1.04 [0.85-1.27],0.6854777969229664
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,43810,572,0.94 [0.87-1.01],0.0933000174172899
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Vascular dementia (undefined),42939,203,0.92 [0.81-1.05],0.2011908413494909
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,42860,160,1.00 [0.87-1.16],0.9839729557531236
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,43120,660,0.95 [0.88-1.02],0.154961229932522
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,43540,387,0.99 [0.90-1.09],0.803220015378872
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,42102,93,0.93 [0.77-1.12],0.4485248713841369
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,42107,98,1.22 [1.01-1.49],0.0415152742283727
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",43623,92,1.11 [0.91-1.35],0.2945537592498736
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,43370,245,0.97 [0.86-1.09],0.5648517651155247
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",3556,85,0.88 [0.72-1.07],0.1977846124081482
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,4292,164,0.94 [0.82-1.09],0.408032101775031
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,42864,164,1.05 [0.91-1.21],0.5373762392320747
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,43471,1747,1.02 [0.98-1.07],0.3231853257773794
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",43182,1173,0.97 [0.92-1.02],0.2136099992234836
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,42384,375,0.97 [0.88-1.07],0.5200719535480651
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",43673,1213,0.97 [0.92-1.02],0.2212214345872886
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,43798,117,1.07 [0.90-1.27],0.4775016114702742
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,43552,1092,0.97 [0.91-1.02],0.2176445060873028
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",43739,614,0.97 [0.90-1.05],0.4322514865229521
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,43650,315,0.97 [0.87-1.07],0.5424069052494785
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,42114,105,1.13 [0.94-1.36],0.1953032898459865
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,42125,116,1.01 [0.85-1.20],0.9184930023936784
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,42104,95,0.98 [0.81-1.19],0.8631375908287191
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,43652,1192,0.97 [0.92-1.03],0.3119129915593364
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,42774,314,0.92 [0.83-1.02],0.1003236255842688
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,42539,79,0.88 [0.72-1.08],0.220891391523236
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,43297,172,0.97 [0.84-1.11],0.646256962959048
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,43581,456,0.96 [0.88-1.05],0.3508414771161469
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,42792,332,0.99 [0.89-1.09],0.7994611861179125
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,43525,190,0.94 [0.83-1.08],0.3981022532031683
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,43238,778,1.00 [0.94-1.07],0.9820449081097724
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,42933,233,1.05 [0.93-1.18],0.4501331076774119
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,41130,3701,1.02 [0.99-1.05],0.210439205672175
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,43522,397,0.96 [0.87-1.05],0.3564726458207833
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,43775,258,1.02 [0.91-1.14],0.747759072149637
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,42713,704,0.97 [0.90-1.04],0.3291816506756639
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,43242,117,0.94 [0.80-1.12],0.488075374886634
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,43774,93,1.07 [0.88-1.31],0.4738098713164836
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,42152,143,0.89 [0.76-1.03],0.1130445596821143
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,42266,257,0.88 [0.79-0.99],0.0338590748798573
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,41923,199,1.07 [0.94-1.22],0.305533975344831
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,42556,96,0.91 [0.75-1.09],0.2950032165048373
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",41836,112,0.91 [0.77-1.08],0.2926707152194521
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,42605,145,0.92 [0.79-1.07],0.2924684813880018
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",42785,325,0.96 [0.87-1.06],0.4048966232366939
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,42218,209,1.03 [0.90-1.17],0.6701238306131625
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,41913,189,1.25 [1.09-1.44],0.0017304047699079
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,41858,134,1.01 [0.86-1.19],0.8933163178497654
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,40432,3003,0.99 [0.96-1.02],0.5534725803233673
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,42134,125,0.99 [0.84-1.16],0.8708938649423982
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,43390,690,1.06 [0.99-1.14],0.1084060478982015
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,42800,100,1.10 [0.91-1.33],0.301369529415925
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),42966,266,0.99 [0.89-1.11],0.8896864435100879
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,43433,152,0.87 [0.75-1.01],0.0682378095019261
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,43733,200,0.99 [0.87-1.13],0.9382448535348482
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,43587,219,1.04 [0.92-1.18],0.5301380603297987
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,43390,109,1.00 [0.84-1.19],0.9653652180082044
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,43388,107,1.10 [0.91-1.32],0.3272372154932149
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,43634,1487,1.01 [0.97-1.06],0.5778722142291794
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,43210,1063,1.03 [0.97-1.09],0.3023680431136046
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,42357,210,0.91 [0.81-1.03],0.1513701563345913
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VIII Diseases of the ear and mastoid process,Tinnitus,42293,146,1.14 [0.97-1.33],0.1096528517135322
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Acute pharyngitis,43383,118,0.90 [0.76-1.06],0.1989487639753284
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Acute upper respiratory infections,43625,360,0.96 [0.87-1.06],0.4276605681103417
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,43370,105,0.92 [0.77-1.10],0.3441412347443243
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,All influenza,40440,199,1.02 [0.89-1.16],0.8220528649554564
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,All influenza (not pneumonia),40436,195,1.03 [0.91-1.18],0.6173571968862077
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Allergic asthma (mode),30029,200,1.11 [0.97-1.27],0.1247261890760109
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Allergic rhinitis,43604,476,1.07 [0.98-1.17],0.1119352224046787
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",32413,3033,1.04 [1.01-1.08],0.016345134390395
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",32814,2985,1.04 [1.01-1.08],0.0180369128408042
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),43120,239,1.08 [0.96-1.22],0.2033824841351582
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",40379,138,1.15 [0.98-1.35],0.0901140862501405
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Bronchiectasis,37919,589,1.12 [1.04-1.21],0.0041875243687509
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",37427,97,1.24 [1.02-1.51],0.0332173774471506
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,42082,4752,1.04 [1.01-1.06],0.0099379962766937
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",41470,123,1.01 [0.86-1.20],0.8799559679298294
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Chronic sinusitis,41603,256,1.12 [0.99-1.26],0.06370491231695
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",43470,1998,1.01 [0.96-1.05],0.8049771552178826
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Deviated nasal septum,41534,187,1.01 [0.89-1.16],0.8460480543104657
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Diseases of the respiratory system,40283,8866,1.03 [1.01-1.05],0.0013748898405996
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",41975,628,1.01 [0.94-1.09],0.7157571076592198
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Early onset COPD,42025,553,0.99 [0.92-1.07],0.781220540046809
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Emphysema,37868,538,1.08 [1.00-1.17],0.0551233150695395
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,41558,505,1.03 [0.95-1.12],0.5291151028733323
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Influenza and pneumonia,43423,3182,1.01 [0.98-1.05],0.4456378189861699
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Interstitial lung disease,41615,562,1.05 [0.97-1.13],0.2676554693828665
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Later onset COPD,42062,1445,1.02 [0.97-1.07],0.5335142393592998
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Lung diseases due to external agents,43789,516,1.02 [0.94-1.10],0.6663638638371315
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Nasal polyp,41539,192,1.03 [0.90-1.18],0.6237546737281945
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,43374,1628,1.04 [0.99-1.08],0.1383402171312743
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Other diseases of pleura,43412,3353,1.04 [1.01-1.08],0.0134876244421686
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,42772,1425,1.05 [1.00-1.10],0.0601846379379422
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Other pleural conditions,40144,85,0.87 [0.71-1.06],0.1563379356581972
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,43638,694,1.01 [0.94-1.08],0.8589627587454911
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,43631,2200,1.06 [1.02-1.11],0.0020663163508435
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Pleural effusion,41706,1647,1.02 [0.97-1.07],0.386911583443531
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Pleural plaque,40325,266,1.01 [0.91-1.14],0.8096359820508753
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",42997,2756,1.01 [0.97-1.04],0.6618390624218293
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,43675,402,1.03 [0.94-1.13],0.4946262885865023
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Pneumothorax,40268,209,0.99 [0.87-1.12],0.8812763129441079
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Pollen allergy,43775,407,1.09 [0.99-1.20],0.0663339558335171
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Pulmonary oedema,43053,109,0.82 [0.69-0.97],0.0204839025840016
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Respiratory insufficiency,29921,92,1.25 [1.02-1.53],0.0293051555068417
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,43339,1593,1.03 [0.99-1.08],0.180756934914329
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,41824,477,1.08 [0.99-1.17],0.0972527091760893
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Viral pneumonia,40649,408,1.00 [0.91-1.10],0.9851090264624364
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",43148,335,0.98 [0.89-1.09],0.7205274081242365
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Vocal cord dysfunction,20214,187,0.99 [0.86-1.14],0.8881578203785774
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,31029,106,1.02 [0.85-1.22],0.8328677808531137
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Acute appendicitis,43532,240,0.91 [0.81-1.02],0.1157022462018044
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Acute gastritis,33032,143,1.03 [0.88-1.20],0.7258055507747895
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Acute pancreatitis,40688,314,1.03 [0.93-1.15],0.5438460765048694
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Acute peritonitis,43004,151,1.03 [0.89-1.20],0.7051109341434311
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Alcoholic liver disease,42307,127,0.85 [0.73-1.00],0.0468769486198759
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Barrett oesophagus,33632,743,1.03 [0.96-1.10],0.4010879290285355
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",40547,173,1.08 [0.94-1.25],0.2812425155543626
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",43102,173,1.08 [0.94-1.25],0.2957125123879945
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Cholecystitis,40714,340,0.98 [0.89-1.08],0.7102085865537473
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Cholelithiasis,42085,1711,1.02 [0.98-1.07],0.3662119065259579
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Chronic gastritis,33399,510,1.02 [0.94-1.11],0.5599780380487849
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Chronic pancreatitis,40458,84,0.91 [0.75-1.11],0.3459428701806241
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",43564,186,0.84 [0.74-0.96],0.0109777537641411
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Coeliac disease,41116,201,1.11 [0.97-1.26],0.1375164606649129
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Collagenous colitis,40943,135,0.99 [0.84-1.16],0.9042461246112906
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,43544,321,0.94 [0.85-1.04],0.2194416141537742
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Constipation,43380,2760,1.00 [0.97-1.04],0.99579452208007
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Crohn disease,40960,152,1.03 [0.88-1.20],0.7110721730073526
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",43205,108,1.00 [0.83-1.19],0.964118935217852
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Crohn's disease NAS,40949,141,1.03 [0.88-1.20],0.7487364232685385
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Dental caries,42549,381,1.02 [0.93-1.13],0.6398141517275335
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diaphragmatic hernia,39316,3732,1.01 [0.98-1.04],0.7420194019354427
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diseases of appendix,43593,301,0.95 [0.85-1.05],0.319640166892878
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diseases of liver,43604,1424,1.00 [0.95-1.05],0.8898927989147157
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",40125,7236,1.01 [0.99-1.03],0.4462116125675478
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",43098,930,1.03 [0.97-1.09],0.3513182824586899
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diseases of peritoneum,43670,817,1.04 [0.98-1.11],0.2080049133678602
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,42360,192,1.04 [0.91-1.19],0.5343154235697247
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diseases of salivary glands,42119,108,1.07 [0.89-1.28],0.4659873345480544
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diseases of the digestive system,43293,2378,1.01 [0.97-1.05],0.6733332417278203
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diseases of tongue,42129,183,1.03 [0.90-1.18],0.7031694345262747
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",42772,2398,1.02 [0.98-1.06],0.342374415784401
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diverticular disease of intestine,36262,5339,1.00 [0.98-1.03],0.94651526971562
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Duodenal ulcer,33220,331,1.03 [0.93-1.14],0.6097289664201698
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",43660,263,1.04 [0.93-1.17],0.4836688096959036
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Embedded and impacted teeth,43670,90,1.25 [1.02-1.53],0.0339118316583833
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,42402,222,0.89 [0.79-1.01],0.0629411149712911
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,31171,248,0.97 [0.86-1.09],0.5606771474414527
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Functional dyspepsia,33826,937,1.03 [0.97-1.09],0.3633140890302679
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Gastric ulcer,33494,605,0.98 [0.91-1.06],0.5881052010438335
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,37094,4205,1.01 [0.98-1.04],0.4961352774847688
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,33792,903,0.99 [0.94-1.06],0.868480664921148
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Gastrointestinal diseases,33907,13937,1.01 [0.99-1.03],0.2524935452866988
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,GI-bleeding,42847,1932,0.99 [0.95-1.03],0.5494458382024492
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,42272,104,1.07 [0.89-1.29],0.4543952716639006
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,32554,2110,1.01 [0.97-1.05],0.6667885043677255
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",42284,104,0.86 [0.72-1.03],0.0977264768082805
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Hernia,41030,5446,1.01 [0.99-1.04],0.3211972752282224
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Impacted teeth,43681,84,1.35 [1.09-1.67],0.005918220816197
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Impaction of intestines,31019,96,1.00 [0.82-1.21],0.982245610961252
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Inguinal hernia,37109,1525,1.03 [0.98-1.08],0.2755294328399374
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",35753,169,0.98 [0.85-1.13],0.7638350424356428
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,31082,159,0.90 [0.78-1.04],0.1474629243162408
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Intestinal malabsorption,41156,241,1.11 [0.98-1.26],0.0907308279284483
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Irritable bowel syndrome,31857,934,1.03 [0.97-1.10],0.320472272792241
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,43761,617,1.10 [1.02-1.18],0.0180514380346633
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,42084,1276,1.06 [1.01-1.12],0.0274520339159873
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,42506,1698,1.05 [1.00-1.10],0.0390030506926856
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Oesophageal obstruction,33196,307,1.01 [0.91-1.12],0.8392673589854031
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Oesophagitis,33911,1022,1.04 [0.98-1.10],0.2449788393203409
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Oral lichen ruber planus,43721,229,1.04 [0.92-1.18],0.5481103402349131
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,35695,111,1.19 [0.99-1.43],0.0586481782673523
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,33217,2294,1.01 [0.97-1.05],0.7768289915799907
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of biliary tract,40843,469,0.99 [0.91-1.07],0.7622521171601098
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of gallbladder,40640,266,0.98 [0.88-1.10],0.7560170632503989
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of intestine,33893,2970,0.99 [0.96-1.02],0.5874425847239733
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of intestines,40387,9464,0.99 [0.97-1.01],0.3349055276581988
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,42100,351,1.04 [0.94-1.15],0.4296129062077496
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of liver,43341,1161,1.00 [0.94-1.05],0.876160190178485
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of oesophagus,34027,1138,1.01 [0.95-1.06],0.7816743085059407
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of pancreas,40620,246,0.94 [0.84-1.06],0.3244335396943801
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of peritoneum,43557,704,1.05 [0.98-1.12],0.2005517285949643
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,34485,1596,0.99 [0.95-1.04],0.8047268843022821
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of the digestive system,42873,1958,0.99 [0.95-1.03],0.5867009422740059
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,42467,299,0.99 [0.89-1.11],0.9086310838382606
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other functional intestinal disorders,33764,2841,1.00 [0.96-1.03],0.8299785665373397
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),36262,3373,0.98 [0.95-1.01],0.2155103485310697
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,42351,171,0.89 [0.77-1.02],0.0947636289560939
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,42297,1489,1.04 [0.99-1.09],0.1201028620487469
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",31501,578,0.98 [0.91-1.06],0.6932194951201864
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Palatinal maxillary canine,43652,107,1.22 [1.01-1.47],0.0376454653405894
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,31745,822,0.95 [0.90-1.02],0.1565497586696924
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",41176,261,1.07 [0.96-1.21],0.2326320037044765
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Recurring oral aphthae,43788,96,0.89 [0.74-1.07],0.2216220074436744
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Stomatitis and related lesions,42173,190,1.01 [0.88-1.15],0.8935742281007605
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Toxic colitis,40901,93,0.90 [0.75-1.09],0.3012047210408763
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Ulcer of oesophagus,33357,468,1.06 [0.97-1.16],0.1702373790282958
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Ulcerative colitis,41083,275,1.11 [0.99-1.24],0.071782810073377
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",41038,230,1.09 [0.96-1.23],0.1679080866240995
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Umbilical hernia,36039,455,0.94 [0.86-1.02],0.1602402864605013
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,31218,295,0.94 [0.85-1.05],0.2921491819705882
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Ventral hernia,36019,435,1.05 [0.96-1.15],0.2888800544330889
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Volvulus,31056,133,0.90 [0.77-1.05],0.1696654784925973
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,43682,487,1.02 [0.94-1.11],0.654170524132837
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,43270,133,0.96 [0.82-1.12],0.6138306285982851
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,40389,269,1.02 [0.91-1.14],0.7295539564581229
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,42715,1185,0.98 [0.92-1.03],0.3535252436608692
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",41828,298,1.06 [0.95-1.18],0.2868083056513865
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,40761,641,0.94 [0.88-1.02],0.127198081148447
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,43288,465,1.07 [0.98-1.17],0.1241155726989965
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,43626,803,1.03 [0.96-1.10],0.4342322369631324
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,42907,84,1.04 [0.85-1.27],0.7323130859599902
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,41163,5368,0.99 [0.97-1.02],0.5650978354200201
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,43038,737,0.95 [0.88-1.01],0.1032951352489492
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,42813,512,0.97 [0.89-1.05],0.4013233484227828
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,43130,1600,0.98 [0.94-1.03],0.4418988305865273
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",43782,90,1.03 [0.85-1.26],0.7561785866666819
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,40228,108,0.95 [0.80-1.13],0.5754824029668796
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,42392,91,0.97 [0.80-1.18],0.7924012567885595
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,43270,447,1.07 [0.98-1.16],0.1586212232941731
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,40887,767,1.03 [0.96-1.10],0.4021616166910239
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,40234,114,0.94 [0.80-1.12],0.5062293376523817
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,43662,138,0.93 [0.80-1.09],0.3555873443579004
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,41832,302,1.08 [0.97-1.20],0.1801696043318957
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,43466,329,0.91 [0.82-1.00],0.0508409142099684
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,42922,99,0.95 [0.79-1.14],0.5518198451392498
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,40229,109,0.92 [0.78-1.10],0.3649744659411724
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,42836,2716,1.00 [0.96-1.03],0.8595575684203426
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",40952,832,1.04 [0.97-1.10],0.2936384840036359
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,40241,121,0.96 [0.81-1.13],0.5969338700903923
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,43662,525,0.96 [0.88-1.04],0.2854197399889274
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,42941,118,0.94 [0.79-1.11],0.4635958579461761
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,43569,432,0.95 [0.87-1.03],0.227909470935326
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,43725,530,1.01 [0.93-1.09],0.8812071506892808
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,40331,211,1.03 [0.91-1.18],0.6118677475206975
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,40569,449,0.97 [0.89-1.06],0.5598097797348893
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,43708,513,1.00 [0.93-1.09],0.9119030802150754
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",40506,386,1.01 [0.92-1.11],0.8836610570397545
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,43755,231,0.99 [0.88-1.12],0.9050164152090592
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,37570,183,0.99 [0.86-1.13],0.8784446429260769
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,39857,9514,1.01 [0.99-1.03],0.5012542794175274
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,37463,7120,1.00 [0.98-1.03],0.6826005827991252
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,37517,130,1.01 [0.86-1.19],0.892339654008674
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,38021,256,1.03 [0.92-1.16],0.581250529906492
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,38063,298,1.04 [0.93-1.16],0.4738217596559761
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,43391,157,0.87 [0.75-1.01],0.0646684125723784
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",37931,166,0.94 [0.82-1.09],0.4085565295189912
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,32272,1929,1.01 [0.96-1.05],0.7752155500633802
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",43578,324,1.00 [0.91-1.11],0.9238149402056116
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,38485,720,1.02 [0.95-1.10],0.512585019521073
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,37021,12264,1.01 [1.00-1.03],0.1306587014117448
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,40456,200,0.93 [0.81-1.05],0.2447220205091188
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,37641,254,0.95 [0.85-1.07],0.4277779987872746
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,38364,977,1.04 [0.98-1.10],0.223828194518019
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,42218,4453,1.01 [0.98-1.04],0.4752898466906244
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,37858,471,0.99 [0.91-1.08],0.8949536036390296
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,37769,382,1.15 [1.04-1.26],0.0056227069905138
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,37620,233,1.09 [0.96-1.23],0.1807596182630461
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,42677,116,0.95 [0.80-1.13],0.5483345276020741
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,33174,2831,1.01 [0.97-1.04],0.6918823939495851
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,31331,988,1.06 [1.00-1.12],0.0614247462182922
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",43677,973,1.06 [1.00-1.12],0.0621611775332195
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,30473,130,0.95 [0.81-1.11],0.524172071692791
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),30914,571,0.92 [0.85-0.99],0.0249930262188726
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,37897,510,0.99 [0.91-1.07],0.7555278411628745
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,31418,1075,1.02 [0.97-1.08],0.4310199367852748
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,37857,92,1.18 [0.97-1.44],0.1062609354497006
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,38820,1055,1.02 [0.96-1.08],0.5049531557670476
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,38271,506,1.02 [0.94-1.11],0.6586664349699549
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,31344,1001,1.02 [0.96-1.08],0.6106690991800217
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,37512,125,1.22 [1.03-1.45],0.0238881848124887
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",37490,103,1.02 [0.85-1.22],0.863205892093838
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,40378,122,1.02 [0.86-1.20],0.8481496113270602
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,43157,2901,0.97 [0.94-1.01],0.120889325200469
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,42151,1895,0.97 [0.93-1.01],0.1056642033265165
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",43562,762,1.06 [0.99-1.14],0.0748822601841086
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,34531,4188,1.01 [0.98-1.04],0.5465616634399619
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,30448,105,0.98 [0.82-1.17],0.8006513155497326
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,37541,154,1.09 [0.94-1.27],0.2476710795930968
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,30431,88,0.92 [0.76-1.12],0.3920325395060152
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),30558,215,1.01 [0.89-1.14],0.90253151546557
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,40670,414,0.94 [0.86-1.03],0.2155864757685479
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,40889,633,0.97 [0.90-1.04],0.3539832326286195
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,43759,166,1.10 [0.95-1.27],0.2210202199353401
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",40791,3026,1.02 [0.99-1.05],0.2639928970825748
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,37554,167,0.96 [0.83-1.11],0.581546820209545
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),30583,240,0.94 [0.83-1.06],0.2903577552642753
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,38980,1215,1.01 [0.96-1.07],0.6249058664983473
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,33980,3637,1.01 [0.98-1.04],0.6264335115283686
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,42718,157,1.00 [0.87-1.16],0.9633664289469268
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,43779,125,0.99 [0.84-1.17],0.9360090036742388
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,37525,138,1.05 [0.90-1.23],0.5365289436111186
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",39487,2100,1.04 [1.00-1.09],0.0465188072222822
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,37535,148,0.99 [0.85-1.15],0.8705807661718585
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,33092,2749,1.03 [1.00-1.07],0.0737618123891527
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,40454,198,0.95 [0.84-1.09],0.4830153026222398
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,37474,87,1.10 [0.90-1.35],0.353655229111947
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,38030,265,0.96 [0.86-1.07],0.4769099929892523
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,38305,918,1.02 [0.96-1.08],0.5498151961243818
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,43166,605,1.11 [1.02-1.19],0.0106097915679466
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,38729,964,0.99 [0.94-1.05],0.8362818903287361
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,43582,742,1.07 [1.00-1.15],0.0562037844176102
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,43772,88,1.22 [1.00-1.50],0.0532292784742262
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,37710,323,1.00 [0.90-1.10],0.9394996137098286
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,34679,1269,1.04 [0.99-1.10],0.137619107532819
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,38362,975,1.00 [0.94-1.06],0.9179129096753283
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],37779,392,1.00 [0.91-1.09],0.9348845597528498
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",30442,99,0.98 [0.81-1.18],0.8299758359504635
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,34541,4198,1.04 [1.01-1.07],0.0065626174595873
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,31438,1095,0.97 [0.92-1.03],0.2775494464457919
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,42945,384,1.09 [0.99-1.21],0.0660249093740501
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",43700,107,1.00 [0.84-1.20],0.9906053052034768
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",40181,83,1.17 [0.95-1.44],0.1467514662042681
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,30471,128,0.98 [0.83-1.15],0.7756006632521817
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,37935,170,1.07 [0.93-1.24],0.3503877142405697
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,31115,772,1.06 [0.99-1.14],0.0732741920890703
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,37912,525,0.98 [0.91-1.06],0.6656934288934682
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,38189,424,1.12 [1.02-1.23],0.0148890562508077
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,38071,306,0.97 [0.87-1.08],0.5972202643385707
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,34267,103,1.23 [1.01-1.48],0.0347503622390808
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",43780,96,1.13 [0.93-1.37],0.2249825006795484
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,38381,994,1.00 [0.95-1.06],0.9203832968216548
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],42728,167,1.10 [0.95-1.27],0.1939923097191348
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,41754,4367,1.02 [1.00-1.05],0.0910509433771628
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",37612,225,1.00 [0.88-1.13],0.939782749742082
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,38652,887,1.03 [0.97-1.10],0.3778804068376179
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,41376,389,0.99 [0.91-1.09],0.902002359393472
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,38095,330,1.04 [0.94-1.16],0.4296822660747623
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,40350,2585,1.00 [0.96-1.03],0.8529030304636784
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,39459,1694,0.99 [0.95-1.04],0.7840635924988292
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],37474,87,1.05 [0.86-1.28],0.6408878482810245
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,42811,250,1.07 [0.95-1.21],0.2569374277126006
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,37669,282,1.09 [0.97-1.21],0.1473360782275121
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,37520,133,0.92 [0.79-1.08],0.3093389272262041
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),30439,96,1.05 [0.87-1.27],0.5896624745881581
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Acute renal failure,42224,2532,1.01 [0.97-1.04],0.7152947853144107
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),17745,86,1.14 [0.93-1.40],0.2133776396433336
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,23115,100,0.98 [0.81-1.17],0.7879956543679631
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,43278,534,1.02 [0.94-1.10],0.7126215718172567
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,42888,144,0.93 [0.80-1.09],0.3770485104952862
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,41974,2282,0.98 [0.94-1.02],0.2579268051002845
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,43472,104,0.83 [0.69-0.98],0.0329400015150642
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Cyst of kidney,43429,488,0.98 [0.90-1.06],0.5691446744310749
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Cystitis,38700,392,1.01 [0.92-1.11],0.8237875597085411
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Dialysis,39804,112,1.24 [1.03-1.49],0.021676482626413
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,19048,2777,1.01 [0.98-1.05],0.4657706518189204
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Disorders of breast,23297,282,0.98 [0.88-1.10],0.7811939992099121
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Endometriosis,17808,149,1.05 [0.90-1.22],0.5629702457858715
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",17994,335,0.88 [0.80-0.98],0.0149032577000465
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18515,856,1.03 [0.97-1.10],0.3479578740473336
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,36589,8920,1.00 [0.98-1.02],0.8129311907241913
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,43490,122,0.98 [0.83-1.15],0.7851997382199851
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Hydrocele,16440,169,1.02 [0.88-1.17],0.826780957878108
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Hydronephrosis,39640,469,1.02 [0.94-1.12],0.5948139193447876
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,18448,2177,1.01 [0.97-1.06],0.4955996139401492
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,23229,344,0.95 [0.86-1.05],0.2905001132306782
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),16465,194,0.91 [0.80-1.04],0.1821458939493113
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Irregular menses,23311,107,0.76 [0.64-0.90],0.0013849989288739
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Menorrhagia,17921,262,0.97 [0.87-1.09],0.6624246514174488
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,38431,123,1.04 [0.88-1.24],0.6130042512359515
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,19753,2094,1.00 [0.96-1.04],0.93740147898964
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,16371,100,0.89 [0.74-1.07],0.2048536299248359
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,17780,121,1.04 [0.87-1.23],0.6819383768464531
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",43794,109,1.13 [0.94-1.36],0.1835112386565665
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",43792,115,0.94 [0.79-1.11],0.4785707082229476
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,42027,3719,0.99 [0.96-1.02],0.6960482289413958
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,39516,1208,0.96 [0.91-1.01],0.0980181974317221
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other disorders of breast,23114,99,1.00 [0.83-1.21],0.9802219497752992
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,43701,760,1.01 [0.95-1.08],0.7237696338859725
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,16529,258,1.03 [0.92-1.16],0.6216489909770271
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other disorders of penis,16507,236,0.97 [0.86-1.09],0.5987362567747649
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,16459,188,1.04 [0.91-1.19],0.5675682045964211
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,43745,118,1.01 [0.85-1.20],0.8977047073533695
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,41152,2844,1.01 [0.97-1.04],0.7249609538155448
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,23064,179,1.02 [0.89-1.17],0.7876295862281963
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,17792,133,1.20 [1.02-1.42],0.0316466750874693
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",17994,335,1.02 [0.92-1.13],0.7227607585400542
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,17762,103,1.02 [0.85-1.23],0.8029067494487512
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,17841,182,1.04 [0.91-1.20],0.574707054573464
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,39720,549,1.02 [0.94-1.11],0.5835408526815997
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,43193,252,1.08 [0.96-1.21],0.216312627868843
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Ovarian cyst,17911,252,1.06 [0.94-1.19],0.3357349603454441
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,17749,90,0.92 [0.76-1.12],0.4057266306613876
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,18206,547,1.00 [0.92-1.08],0.9815141056929428
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,17798,139,1.06 [0.91-1.25],0.4441947001246384
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,18164,505,1.01 [0.93-1.10],0.7776481637262764
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,43453,85,0.93 [0.77-1.13],0.4791295138995695
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",16492,221,1.02 [0.90-1.16],0.7394379063191283
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,43436,4265,1.00 [0.97-1.03],0.8771200128188401
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",39370,199,1.03 [0.91-1.18],0.6127090383816735
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,39892,200,0.96 [0.84-1.09],0.5416403809842331
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,42837,93,1.01 [0.83-1.22],0.9175935285181626
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Urethral stricture,38677,369,1.06 [0.96-1.16],0.2717984909627201
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Urolithiasis,43412,668,1.00 [0.93-1.07],0.9586539645085386
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Uterine polyps,17778,119,1.13 [0.95-1.34],0.1827984994444573
